Unlocking the 2023 ASA Guidelines: Updates on Neuromuscular Blockade Monitoring and Antagonism

The 2023 ASA Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade provide critical updates on best practices for managing neuromuscular blocking agents during and after anesthesia.

Christopher Voss, MD, MS, FCCP,
Board-certified in Anesthesiology, Critical Care Medicine, Neurocritical Care Medicine, and Pain Medicine.

Citations

1. Viby-Mogensen J, Jørgensen BC, Ording H. Residual curarization in the recovery room. Anesthesiology. 1979 Feb;50(2):539-41.

2. Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology. 2003 May;98(5):1042-8

3. Kopman AF, Yee PS, Neuman GG. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology. 1997 Apr;86(4):765-71.

4. Ali HH, Utting JE, Gray TC. Stimulus frequency in the detection of neuromuscular block in humans. Br J Anaesth. 1970 Aug;42(8):967-78.

5. Thilen SR, Weigel WA, Todd MM, Dutton RP, Lien CA, Grant SA, et al. 2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: A Report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade. Anesthesiology. 2023 Jan;138(1):13-41. doi: 10.1097/ALN.0000000000004379.

6. Brull SJ, Silverman DG. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg. 1995 Jul;81(1):100-6.

7. Eriksson LI. Reduced hypoxic chemosensitivity following partial neuromuscular blockade in the elderly. Acta Anaesthesiol Scand. 1996 Apr;40(4):437-44.

8. Bevan DR, Donati F. Residual curarization and its relevance to postoperative pulmonary complications. Can J Anaesth. 1992 Sep;39(7):760-3.

9. Cammu G, De Witte J, De Veylder J, Heerman J. Postoperative residual curarization with vecuronium and rocuronium after repetitive postoperative administration of neostigmine: a double-blind randomized controlled trial. Anesth Analg. 2006 May;102(5):1278-82.

10. Saager L, Ma C, Hunn M, Duncan AE, Singh T, Maheshwari K, et al. Sugammadex vs neostigmine for reversal of neuromuscular blockade and effects on postoperative respiratory outcomes: a matched cohort study of surgical patients. Anesth Analg. 2021 Dec 1;133(6):1614-24.

11. Madsen MV, Donati F. Why does neuromuscular block prolong myasthenia gravis? A clinical study. Anesth Analg. 2017 May;124(5):1675-8.

12. Jones RK, Caldwell JE, Brull SJ, Soto RG. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology. 2008 Sep;109(3):816-24.

13. Meyhoff CS, Henningsen AK, Højlund J, Ott N, Kildal AB, Møller AM, et al. Adverse respiratory events in surgical patients using sugammadex compared with neostigmine: a multicenter cohort study. Anesthesiology. 2022 Feb;136(2):243-52.